** Hera Med's Australia-listed shares rise as much as 4.8% to A$0.022, their highest level since Sept 12
** Israel-based maternity technology co signs letter of intent with Founda Health to enter into strategic partnership
** Says it will use Founda's platform to integrate its HeraCARE solution with electronic health records within the hospital systems and ensure better service to expectant mothers
** Stock had fallen 9.5% this year, as of last close
(Reporting by Sherin Sunny in Bengaluru)
((Sherin.Sunny@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.